Act Capital Management, LLC Transcode Therapeutics, Inc. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

A detailed history of Act Capital Management, LLC transactions in Transcode Therapeutics, Inc. stock. As of the latest transaction made, Act Capital Management, LLC holds 6,500 shares of RNAZ stock, worth $2,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,500
Previous 6,500 -0.0%
Holding current value
$2,470
Previous $8,000 12.5%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$1.2 - $3.03 $52,200 - $131,805
-43,500 Reduced 87.0%
6,500 $8,000
Q3 2021

Nov 16, 2021
BUY
$2.37 - $6.45 $118,500 - $322,500
50,000 New
50,000 $150,000

Others Institutions Holding RNAZ

# of Institutions
1
Shares Held
6.5K
Call Options Held
0
Put Options Held
0
View Full List

About Transcode Therapeutics, Inc.

RNAZ Quotes by TradingView
  • Ticker RNAZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,977,200
  • Market Cap $4.93M
  • Description
  • TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs incl...
More about RNAZ
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email